Shortness of breath when walking short distances can occur suddenly or be a chronic condition. It should be evaluated, as it ...

A novel screening approach developed by physicians at the Lewis Katz School of Medicine at Temple University shows ...

Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with ...

The pulmonary arterial hypertension treatment market has witnessed a significant transformation in recent years, driven by advancements in medical research and increasing awareness about rare ...

Yutrepia is an inhaled dry powder formulation of treprostinil approved in the U.S. to improve exercise capacity in PAH and PH ...

A Hundred Experts Urge Strengthening Early Diagnosis of Pulmonary Hypertension in Latin America ...

Pulmonary hypertension (PH) is a rare, progressive, debilitating condition characterised by elevated pulmonary artery ...

Like other inhaled prostaglandins, YUTREPIA may cause acute bronchospasm. Patients with asthma or chronic obstructive pulmonary disease (COPD), or other bronchial hyperreactivity, are at increased ...

Learn 12 critical neurological warning signs that demand emergency care. Recognize dangerous combinations of dizziness, ...

New tools, treatment options, and precision medicine developments are leading to better quality of life and survival for ...

Background Insomnia symptoms are prevalent in older adults and linked to cardiovascular disease (CVD), but the role of ...

Learn about Pulmonary Arterial Hypertension (PAH), its causes, symptoms, diagnosis, and treatment options to manage pulmonary high blood pressure effectively ...